Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats

Journal de Pharmacie de Belgique

Volumn 53, Issue 2, 1998, Pages 87-95

  El Daly, Ezzat S ^a  

^a Suez Canal University   (Egypt)

Author keywords

Cisplatin; Crocus sativus; Cysteine; Nigella sativa; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; CISPLATIN; CYSTEINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE REDUCTASE; IDITOL DEHYDROGENASE; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; CELL PROTECTION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; NONHUMAN; OXIDATION; PHOSPHORYLATION; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CYSTEINE; MALE; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; VITAMIN E;

EID: 0031863041     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ALLAN, S.G., CORNBLEET, M.A., WARRINGTON, P.S., GOLLAND, I.M., LEONARD, C.F. and SMYTH, J.F. (1984): Dexamethasone and high dose efficacy in controlling cisplatin-induced nausea and vomiting. British Medical Journal 289: 878-879.
2. ALLAN, S.G., SMYTH, J.F., HAY, F.G., ROBERT, C.F. and WOLF, C.R. (1986): Protective effect of sodium-2-mercaptoethane sulfonate on the gastrointestinal toxicity of cis-diaminedichloroplatinum. Cancer Research 46: 3569-3573.
3. ANAND, A.J. and BASHEY, B. (1993): Newer insights into cisplatin nephrotoxicily. Ann. Pharmacother. 27 (12): 1519-1525.
4. BALDEW, G. S., HAMER, C. J. A., VAN DEN LOS, G., VERMEULEN, N.P.E., DE GOEJI, J.J.M. and McVIE, J. G. (1989): Selenium induced protection against cisplatin (II). Nephrotoxicity in mice and rats. Cancer Res. 49: 3020-3023.
5. BALLANTYNE, B., MARRS, T. and TURNER, P. (1993) General and Applied Toxicology. M. Stockton Press.
6. BANNISTER, S.J., STERNSON, L.A., REPTA, A.J. and JAMES, G.W. (1977): Measurement of free circulating cis-diamine-cis-dichloroplatinum (II) in plasma. Clinical Chemistry 23: 2258-2262.
7. BERGMEYER, H.U. (1974): Glutathione reductase. In : Methods of Enzymatic Analysis. Vol. 1, pp. 465-466 Verlag Chemie International, Deerfield Beach, Florida.
8. BERGMEYER, H.U. and BERNT, E. (1974a): Lactate dehydrogenase. In : Methods of Enzymatic Analysis (Bergmeyer, H. U., ed.) 2nd English edition. Vol. 2, pp. 574-579 Verlag Chemie Weinheim. Academic Press Inc. New York, San Francisco and London.
9. BERGMEYER, H. U. and BERNT, E. (1974b): Malate dehydrogenase. In: Methods of Enzymatic Analysis (Bergmeyer, H. U., ed.) 2nd English edition. Vol. 2, pp. 613-617. Verlag Chemie Weinheim. Academic press Inc. New York, San Francisco, London.
10. BERGMEYER, H. U., HORDER, M. and REJ, R. (1986a): Method for the measurement of catalytic concentration of enzymes. IFCC method for aspartate aminotransferase. J. Clin. Chem. Clin. Biochem. 24: 497-510.
11. BERGMEYER, H. U., HORDER, M. and REJ, R. (1986b): Method for the measurement of catalytic concentration of enzymes. IFCC method for alanine aminotransferase. J. Clin. Chem. Clin. Biochem. 24 : 481-495.
12. BERNT, E. and BERGMEYER, H. U. (1974) Isocitrate dehydrogenase. In: Methods of Enzymatic Analysis (Bergmeyer, H. U., ed.) 2nd English edition. pp. 624-627. Verlag Chemie Weinheim, Acad. Press. Inc. New York, San Francisco and London.
13. BHANUMATHY, P., KUMAR, S. and VASUDEVAN, D.M. (1986): Role of 2-MPG against toxicity of cyclophosphamide in normal and tumour bearing mice. Indian Journal of Experimental Biology 24: 767-770.
14. BOGIN, E., MAROM, M. and LEVI, Y. (1994): Changes in serum, liver and kidneys of cisplatin-treated rats; effects of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 32 (11) : 843-851.
15. BONDER, R. J. L. and MEAD, D. C. (1974) Evaluation of glucose-6-phosphate dehydrogenase from Leuconostic mesenteroides in the hexokinase method for determining glucose in serum. Clin. Chem. 20: 586-590.
16. BOOGAARD, P. J., LEMPERS, E. L. M., MULLER, G. J. and MEERMAN, J. H. N. (1991) U-Methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity. Biochem. Pharmacol. 41, 369-375.
17. BORCH, R.F. (1987): The platinum antitumor drugs. In Metabolism and actions of anticancer drugs, ed. by G. Powis and R.A. Prough, pp. 163-193, Taylor and Francis, New York.
18. BORCH, R.F. and PLEASANTS, M.E. (1979) Inhibition of cisplatin nephrotoxicity by diethyl-dithiocarbamate rescue in a rat model. Proceedings National Academy of Science 76: 6611-6614.
19. CAFRUNY, E. J., FARAH, A. and DISTEFANO, H.S. (1955): Effect of the mercurial diuretic mersalyl on protein-bound sulfhydryl groups in cytoplasm of rat kidney cells. J. Pharmacol. Exp. Ther. 115: 390-401.
20. DECONTI, R.C., TOFTNESS, B.R. LANGE, R.C. and GREASEY, W.A. (1973): Clinical and pharmacological studies with cis-dichloro-diamine-dichloroplatinum (II). Cancer Research 33: 1310-1315.
21. DOUMAS, B. T., WATSON, W. A. and BIGGS, H. G. (1971): Albumin Standards and the measurement of serum albumin with bromocresolgreen. Clin.Chim. Acta 31: 87-96.
22. EVANS, R.G., WHEATLEY, C.E. NIELSEN, J. and CIBOROWOSKI, I. (1984): Modification of the bone marrow toxicity of cis-diamine-dichloroplatinum (II) in mice by diethyldithiocarbamate. Cancer Research 44: 3686-3689.
23. FRINGS, C. S., FENDLY, T. W., DUNN, R. T. and QUEEN, C. A. (1972): Improved determination of total serum lipids by the sulphophosphovanillin reaction. Clin. Chem. 18: 673-674.
24. GERLACH, U. and HIBY, W. (1974): L-Iditol dehydrogenase. In: Methods of Enzymatic Analysis (Bergmeyer, H.U., ed.) Vol. 1, pp. 569-573. Verlag Chemie Weinheim, Academic Press, New York, San Francisco and London.
25. HANIGAN, M.H., GALLAGHER, B.C., TAYLOR, P.T. Jr. and LARGE, M.K. (1994): Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res. 54 (22): 5925-5929.
26. HASCHEK, W.M. and ROUSSEAUX, C.G. (1991): Handbook of Toxicologic Pathology. Academic Press. San Diego, New York Boston, London, Sydney, Tokyo, Toronto.
27. HIDAKA, S., TSURUOKA, M., FUNAKOSHI, T. SHIMADA, H., KIYOZUMI, M. and KOJIMA, S. (1994): Protective effects of dithiocarbamates against renal toxicity of cis-diamine dichloroplatinum in rats. Renal Failure 16 (3): 337-349.
28. HOPKINS, H.A. KOVACS, C.J., LOONEY, W.B., WAKEFIELD, J.A. and MORRIS, H.P. (1976): Cancer biochemistry. Biophysics 1: 303-306.
29. HOWE-GRANT, M.E. and LIPPARD, S.J. (1980): Aqueous platinum (II) chemistry, binding to biological molecules. In : Metal Ions in Biological Systems. Marcel Decker Inc. New York, pp. 63-125.
30. HSU, R. Y. and LARDY, H. A. (1969): Malic enzyme. In : Methods in Enzymology (Colowick, S. P. & Kaplan, N. O., eds.) Vol. 23 pp. 230-235. Academic Press, New York and London.
31. JOHNSON, D. and LARDY, H. (1967): Isolation of liver or kidney mitochondria. In : Methods in Enzymology (Eastbrook, R. W. & Pullman, M. E., eds.) Vol. 10, pp. 94-103. Academic Press, New York, San Francisco, London.
32. LAWRENCE, D.L., ENGELSBERG, B.N., FARID, R.S., HUGHES, E. N. and BILLINGS, P.C. (1993): Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA. J. Biol. Chem. 268(32): 23940-23945.
33. LEVI J., JACOBS, C., KALMAN, S., MCTIGHE, M. and WEINDER, M. W. (1980): Mechanism of cis-platinum nephrotoxicity. I. Effect on SH groups in rat kidney. J. Pharmacol. Exp. Ther. 213: 545-550.
34. LITTERST, C. L. (1981): Alterations in the toxicity of cisplatin and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration. Toxicol. Appl. Pharmacol. 61: 99-108.
35. LOHR, G. W. and WALLER, H. D. (1974): Glucose-6-phosphate dehydrogenase. In : Methods of enzymatic analysis (Bergmeyer, H. U., ed.) 2nd English edition. Vol. 2, pp. 636-643: Verlag Chemie Weinheim, Academic press Inc., New York, San Francisco. London.
36. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L. and RANDALL, R.L. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
37. MCCOMB, R. B. and BOWERS, G. N. (1972) Study of optimum buffer condition for measurement of alkaline phosphatase activity in human serum. Clin. Chem. 18: 97-104.
38. MILAS, L., HUNTER, N., REID, B.O. and THOMAS, H.D. JR. (1982): Protective effect of S-2-(3-amino propylamino ethyl) phosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice. Cancer Research 42: 1888-1897.
39. MILAS, L., HUNTER, N., ITO, H. and PETERS, L.J. (1984): Effect of tumour type, size and end point on tumour protection by WR-2721. International Journal oj Radiation Oncology-Biology Physics 10: 41-48.
40. NAIR, S.C., SALOMI, M.J., PANIKKAR, B. and PANIKKAR K.R. (1991): Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-mduced toxicity in mice. J. Ethnopharmacology 31:75-83.
41. PARPART, A. K., LORENZ, R. B. and PARPART, E. (1947): The osmotic resistance of human red cells. J. Clin . Invest. 26: 636-640.
42. PHILLIPS, T.L. (1980): Rationale for initial clinical trials and future development of radioprotectors. Cancer Clinical Trials 3: 165-173.
43. REISHUS, J.W. and MARTIN, D.S. (1961): cis-dichloro-diamineplatinum (II). Acid hydrolysis and isotopic exchange of chloride ligands. Journal of American Chemical Society 83: 2457-2462.
44. RILEY, C.M. STERNSON, L.A. REPT, A. J. and SLYTER, S.A. (1982): Reactivity of cis-dichloro-diamineplatinum (II) towards selected neucleophiles. Polyhedron 1: 201-202.
45. SAUSEN, P.J., ELFARRA, A.A. and COOLY, A.J. (1992): Methimazole protection of rats against chemically induced kidney damage in vitro. J. Pharm. Exp. Ther. 260(1): 393-401.
46. SLATER, T.F., AHMED, M. and IBRAHIM, S.A. (1977): Studies on the nephrotoxicity of cisplatin (II) and related substances. Journal of Clinical Hematology and Oncology 7: 534-544.
47. SMITH, A. L. (1967): Preparation, Properties and conditions for assay of mitochondria . In : Methods in Enzymology (Eastbrook, R. W. & Pullman, M. E., eds.) Vol. 10, pp. 81-93 Academic Press, New York, San Francisco, London.
48. SZASZ, G. (1974): Reaction rate method for gamma glutamyl-transferase activity in serum. Clin. Chem. 22: 2051-2055.
49. TRESKES, M., BOVEN, E., HOLWERDA, U., PINEDO, H.M. and VAN DER VIJGH, W.J. (1992): Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR 2721 in the mouse. Cancer Res. 52(8): 2257-2260.
50. WEISS, R.B. and CHRISTIAN, M.C. (1993): New cisplatin analogues in development. Drugs 46(3): 360-377.
51. WINTROBE, M.M. (1974): Pancytopenia, aplastic anemia and "pure red cell" aplasia. In: M.M. Wintrobe G.R. Lee, D.R. Boggs, T.C. Bithell, J.W. Athens and J. Foerster (Eds.). Clinical Hematology, Lee and Febiger. Philadelphia, pp. 1741-1776.
52. YUHAS, J.M., SPELLMAN, J.M. and CULO, F. (1980): The role of WR-2721 in radiotherapy and or chemotherapy. Cancer Clinical Trials 3:211-216.